MATTHEW W. FOEHR - 03 Jan 2022 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 18:08:35 UTC
Previous filing
12 Nov 2021
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Award $0 +22,000 $0.000000 22,000 03 Jan 2022 Common Stock 22,000 $4.88 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.